Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

By E. Loftus. Gastroenterology, 2004

3,211 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/2cb2c2646e1d8e2ee948544c79704d546b3d68e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Joel T. Dudley
2. B. B. Finlay
3. Julian Parkhill
4. Atul J. Butte
5. Sunil K. Lal
6. Lan Lin
7. Stefan Schreiber
8. Judy H. Cho

In Genetics

1. Mark J. Daly
2. Judy H. Cho
3. David Altshuler
4. Benjamin M. Neale
5. Stefan Schreiber
6. Joel T. Dudley
7. Andre Franke
8. P. Rutgeerts

In Public Health, Environmental and Occupational Health

1. Julian Parkhill
2. Sunil K. Lal
3. Lan Lin
4. Stefan Schreiber
5. Judy H. Cho
6. Jianqiong Zhang
7. Z. Y. Kho

Citations in the corpus

• Recent Advances in Understanding Enteric Pathogenic Escherichia coli (2013, background): “2 million persons in Europe suffer from this debilitating disease (848).”
• The Impact of the Gut Microbiota on Human Health: An Integrative View (2012, neutral): “Studies of twins discordant for Crohn's suggest that an environmental aspect is required for the development of the disease (Halfvarson et al., 2006; Loftus, 2004).”
• The Human Gut Microbiome – A Potential Controller of Wellness and Disease (2018, background): “The occurrence of IBD is rising at alarming rate worldwide, estimating 1.4 million and 2.2 million individuals in America and Europe, respectively (Loftus, 2004).”
• High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease (2011, background): “Inflammatory bowel disease (IBD) encompasses both Crohn’s disease (CD) and ulcerative colitis (UC), chronic inflammatory disorders of the gastrointestinal tract with developed world predominance and an incidence that has risen dramatically in the post-war period [1].”
• Role of intestinal microbiota and metabolites on gut homeostasis and human diseases (2017, background): “Defects in mucosal tolerance are believed to cause human disorders including inflammatory bowel disease (IBD) exemplified by Crohn’s disease and ulcerative colitis [5].”
• The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study (2006, background): “To date the only population-based North American data of IBD epidemiology came from MB and Olmsted County, Minnesota.”
• The genetics and immunopathogenesis of inflammatory bowel disease (2008, background): “Patients with IBD often have various extra-intestinal symptoms such as arthalgias , and are more likely to have other chronic inflammatory diseases, particularly primary sclerosing cholangitis, ankylosing spondylitis and psoriasi”
• Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. (2014, background): “Interestingly, tobacco smoking has a protective effect in ulcerative colitis, which highlights the pathogenic differences between Crohn’s disease and ulcerative colitis and reflects the complex mixture of compounds found in tobacco smoke (113, 169).”
• Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease (2011, background): “D ow nl oa de d fr om INTRODUCTION Inflammatory bowel disease (IBD), of which Crohn’s disease (CD) and ulcerative colitis (UC) are the most common clinically defined manifestations, represents a group of chronic, progressive inflammatory disorders of the intestinal tract that affects more than 1 mil”